135 related articles for article (PubMed ID: 32729306)
21. p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved.
Walsh NM; Saggini A; Pasternak S; Carter MD; Fleming K; Ly TY; Doucette S
Hum Pathol; 2020 Mar; 97():60-67. PubMed ID: 31978504
[TBL] [Abstract][Full Text] [Related]
22. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.
Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B
Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585
[TBL] [Abstract][Full Text] [Related]
23. Utility of p40 in the Differential Diagnosis of Small Round Blue Cell Tumors of the Sinonasal Tract.
Tilson MP; Bishop JA
Head Neck Pathol; 2014 Jun; 8(2):141-5. PubMed ID: 24114197
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
25. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis.
Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ
Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932
[TBL] [Abstract][Full Text] [Related]
26. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER
Liu Y; Nekulova M; Nenutil R; Horakova I; Appleyard MV; Murray K; Holcakova J; Galoczova M; Quinlan P; Jordan LB; Purdie CA; Vojtesek B; Thompson AM; Coates PJ
J Pathol Clin Res; 2020 Jan; 6(1):83-93. PubMed ID: 31591823
[TBL] [Abstract][Full Text] [Related]
27. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma.
Alomari AK; Glusac EJ; McNiff JM
J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848
[TBL] [Abstract][Full Text] [Related]
28. Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumours.
D'Alfonso TM; Ross DS; Liu YF; Shin SJ
J Clin Pathol; 2015 Jul; 68(7):516-21. PubMed ID: 25795733
[TBL] [Abstract][Full Text] [Related]
29. Technical note: p40 antibody as a replacement for p63 antibody in bovine mammary immunohistochemistry.
Parsons CLM; Tucker HLM; Akers RM; Daniels KM
J Dairy Sci; 2018 Aug; 101(8):7614-7617. PubMed ID: 29729907
[TBL] [Abstract][Full Text] [Related]
30. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
[TBL] [Abstract][Full Text] [Related]
31. Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases.
Němejcová K; Cibula D; Dundr P
Diagn Pathol; 2015 Mar; 10():8. PubMed ID: 25884453
[TBL] [Abstract][Full Text] [Related]
32. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
[TBL] [Abstract][Full Text] [Related]
33. An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers.
Tacha D; Bremer R; Haas T; Qi W
Arch Pathol Lab Med; 2014 Oct; 138(10):1358-64. PubMed ID: 24528495
[TBL] [Abstract][Full Text] [Related]
34. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases.
Wang TY; Chen BF; Yang YC; Chen H; Wang Y; Cviko A; Quade BJ; Sun D; Yang A; McKeon FD; Crum CP
Hum Pathol; 2001 May; 32(5):479-86. PubMed ID: 11381365
[TBL] [Abstract][Full Text] [Related]
35. Utilization of p40 (ΔNp63) with p63 and cytokeratin 5/6 immunohistochemistry in non-small cell lung carcinoma fine-needle aspiration biopsy.
Collins BT; Wang JF; Bernadt CT
Acta Cytol; 2013; 57(6):619-24. PubMed ID: 24107322
[TBL] [Abstract][Full Text] [Related]
36. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology.
Khazai L; Agosto-Arroyo E; Rosa M
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):599-604. PubMed ID: 28549030
[TBL] [Abstract][Full Text] [Related]
37. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens.
Brandler TC; Aziz MS; Rosen LM; Bhuiya TA; Yaskiv O
Cancer Cytopathol; 2014 Jun; 122(6):468-73. PubMed ID: 24711443
[TBL] [Abstract][Full Text] [Related]
39. High expression of p63 is correlated to poor prognosis in squamous cell carcinoma of the tongue.
Loljung L; Coates PJ; Nekulova M; Laurell G; Wahlgren M; Wilms T; Widlöf M; Hansel A; Nylander K
J Oral Pathol Med; 2014 Jan; 43(1):14-9. PubMed ID: 23607508
[TBL] [Abstract][Full Text] [Related]
40. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
Chen YK; Hsue SS; Lin LM
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
